Indivior (INDV) was upgraded by Zacks Research from "hold" to "strong-buy".
Indivior (INDV) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder [Yahoo! Finance]
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
How Indivior's Upsized $450 Million Convertible Notes and Buybacks May Impact Indivior (INDV) Investors [Yahoo! Finance]